AbbVie and Scripps Research institute’s division Calibr have announced a broadened strategic collaboration targeted at developing preclinical and early-stage clinical assets across a host of therapeutic areas such as immunology, oncology, and neuroscience. The extended partnership which aligns with AbbVie’s core areas of interest builds upon the company’s 2019 partnership with Scripps Research. Thomas Hudson, […]
Laurus Labs said that it has acquired a stake of 26.62% in Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an Indian cell and gene therapy company for a sum of around INR 46 crores in cash. Apart from that, ImmunoACT will also get an investment of INR 9.75 crores from its senior management for a stake […]
Thermo Fisher Scientific has entered into a significant agreement with Chinese cell therapy leader JW Therapeutics, granting non-exclusive commercial access to its Gibco CTS Dynabeads CD3/CD28 technology. This collaboration is set to accelerate the clinical development and commercial manufacturing of CAR-T therapies in China, focusing on JW Therapeutics’ pioneering product, relmacabtagene autoleucel (relma-cel). Enhancing CAR-T […]
